N
RETA

Natixis’s Reata Pharmaceuticals, Inc. Class A Common Stock RETA Stock Holding History

Natixis’s Portfolio RETA Stock Details RETA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-3,657
Closed -$748K – 923
2019
Q4 		$748K Buy
+3,657
New +$748K ﹤0.01% 675